JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1776
Valvoline
VVV
$3.93B
| $21.2M | ﹤0.01% |
564,366
+199,336
| +55% | +$6.67M |
2016 Q3
29 quarters
|
|
1777
CALL
Target
TGT
$71.2B
| $21.1M | ﹤0.01% |
148,500
+114,000
| +330% | +$13.9M |
2020 Q3
13 quarters
|
|
1778
Avantor
AVTR
$10.2B
| $21.1M | ﹤0.01% |
925,924
+16,643
| +2% | +$341K |
2019 Q2
18 quarters
|
|
1779
CALL
Blackstone
BX
$84.3B
| $21.1M | ﹤0.01% |
161,100
-111,000
| -41% | -$12M |
2022 Q2
6 quarters
|
|
1780
CALL
Elanco Animal Health
ELAN
$10.9B
| $21.1M | ﹤0.01% |
+1,414,200
| New | +$16M |
2023 Q4
0 quarters
|
|
1781
WSFS Financial
WSFS
$3.91B
| $21M | ﹤0.01% |
457,506
+161,061
| +54% | +$6.32M |
2013 Q2
42 quarters
|
|
1782
PUT
Sarepta Therapeutics
SRPT
$1.86B
| $21M | ﹤0.01% |
217,400
+139,100
| +178% | +$13.3M |
2022 Q3
5 quarters
|
|
1783
Independence Realty Trust
IRT
$3.42B
| $20.8M | ﹤0.01% |
1,361,425
+80,628
| +6% | +$1.12M |
2016 Q1
31 quarters
|
|
1784
PUT
Bristol-Myers Squibb
BMY
$126B
| $20.8M | ﹤0.01% |
405,800
-365,800
| -47% | -$19.2M |
2014 Q2
38 quarters
|
|
1785
Orion
OEC
$319M
| $20.7M | ﹤0.01% |
747,227
-75,704
| -9% | -$1.74M |
2016 Q1
31 quarters
|
|
|
CMA
1786
DELISTED
Comerica
CMA
| $20.7M | ﹤0.01% |
371,223
-357,954
| -49% | -$16.2M |
2013 Q2
42 quarters
|
|
|
PMT
1787
PennyMac Mortgage Investment
PMT
$677M
| $20.7M | ﹤0.01% |
1,385,320
-624,734
| -31% | -$8.38M |
2017 Q4
24 quarters
|
|
1788
Acadia Pharmaceuticals
ACAD
$3.43B
| $20.7M | ﹤0.01% |
660,900
+202,985
| +44% | +$4.85M |
2013 Q2
42 quarters
|
|
1789
PUT
Aon
AON
$58.5B
| $20.7M | ﹤0.01% |
71,100
+13,100
| +23% | +$4.19M |
2022 Q1
7 quarters
|
|
1790
PUT
Hartford Financial Services
HIG
$34.1B
| $20.7M | ﹤0.01% |
257,200
+90,000
| +54% | +$6.78M |
2022 Q2
6 quarters
|
|
1791
Evertec
EVTC
$1.64B
| $20.6M | ﹤0.01% |
504,256
+11,765
| +2% | +$432K |
2013 Q2
42 quarters
|
|
1792
Highwoods Properties
HIW
$3.21B
| $20.6M | ﹤0.01% |
897,480
+224,897
| +33% | +$4.48M |
2013 Q2
42 quarters
|
|
1793
Zurn Elkay Water Solutions
ZWS
$7.83B
| $20.6M | ﹤0.01% |
699,830
+427,927
| +157% | +$12.1M |
2013 Q2
42 quarters
|
|
1794
PUT
PayPal
PYPL
$45.4B
| $20.6M | ﹤0.01% |
335,000
+161,100
| +93% | +$9.23M |
2015 Q3
33 quarters
|
|
1795
CALL
Cheniere Energy
LNG
$56.3B
| $20.6M | ﹤0.01% |
120,500
-10,700
| -8% | -$1.84M |
2023 Q1
3 quarters
|
|
1796
Bank OZK
OZK
$5.05B
| $20.6M | ﹤0.01% |
412,718
-45,166
| -10% | -$1.86M |
2013 Q2
42 quarters
|
|
1797
PUT
Applied Materials
AMAT
$420B
| $20.6M | ﹤0.01% |
126,800
+33,400
| +36% | +$4.91M |
2018 Q4
20 quarters
|
|
1798
Primerica
PRI
$8.46B
| $20.5M | ﹤0.01% |
99,802
+13,149
| +15% | +$2.69M |
2013 Q2
42 quarters
|
|
1799
Avantis US Small Cap Value ETF
AVUV
$30.6B
| $20.5M | ﹤0.01% |
228,186
+213,613
| +1,466% | +$17.1M |
2022 Q3
5 quarters
|
|
1800
G-III Apparel Group
GIII
$1.18B
| $20.4M | ﹤0.01% |
601,772
+197,064
| +49% | +$5.54M |
2013 Q2
42 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.